• 1
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 6990.
  • 2
    Jankowski JA, Odze RD. Biomarkers in gastroenterology: between hope and hype comes histopathology. Am J Gastroenterol 2009; 104: 10936.
  • 3
    Han W, Ding P, Xu M et al. Identification of eight genes encoding chemokine-like factor superfamily members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation. Genomics 2003; 81: 60917.
  • 4
    Shao L, Li T, Mo X et al. Expressional and functional studies of CKLF1 during dendritic cell maturation. Cell Immunol 2010; 263: 18895.
  • 5
    Wang Y, Li T, Qiu X et al. CMTM3 can affect the transcription activity of androgen receptor and inhibit the expression level of PSA in LNCaP cells. Biochem Biophys Res Commun 2008; 371: 548.
  • 6
    Wang Y, Li J, Cui Y et al. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Res 2009; 69: 5194201.
  • 7
    Song HS, Shi S, Lu XZ et al. Intracellular CMTM2 negatively regulates human immunodeficiency virus type-1 transcription through targeting the transcription factors AP-1 and CREB. Chin Med J (Engl) 2010; 123: 24405.
  • 8
    Plate M, Li T, Wang Y et al. Identification and characterization of CMTM4, a novel gene with inhibitory effects on HeLa cell growth through Inducing G2/M phase accumulation. Mol Cells 2010; 29: 35561.
  • 9
    Niu J, Li H, Zhang Y et al. Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia. Leuk Res 2011; 35: 7716.
  • 10
    Zhang W, Mendoza MC, Pei X et al. Down-regulation of CMTM8 induces epithelial-to-mesenchymal transition-like changes via c-MET/extracellular signal-regulated kinase (ERK) signaling. J Biol Chem 2012; 287: 118508.
  • 11
    Lind GE, Ahlquist T, Kolberg M et al. Hypermethylated MAL gene – a silent marker of early colon tumorigenesis. J Transl Med 2008; 6: 13.
  • 12
    Buffart TE, Overmeer RM, Steenbergen RD et al. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. Br J Cancer 2008; 99: 18027.
  • 13
    Shao L, Cui Y, Li H et al. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines. Clin Cancer Res 2007; 13: 575662.
  • 14
    Ajani JA, Barthel JS, Bekaii-Saab T et al. Gastric cancer. J Natl Compr Canc Netw 2010; 8: 378409.
  • 15
    Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 3rd English edition. Gastric Cancer 2011; 14: 10112.
  • 16
    Li Z, Zhan W, Wang Z et al. Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis. Biochem Biophys Res Commun 2006; 348: 22937.
  • 17
    Carvajal-Carmona LG, Cazier JB, Jones AM et al. Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate target genes. Hum Mol Genet 2011; 20: 287988.
  • 18
    Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 36274.
  • 19
    Li X, Cheung KF, Ma X et al. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients. Oncogene 2012; 31: 341930.
  • 20
    Hou Q, Wu YH, Grabsch H et al. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. Cancer Res 2008; 68: 462330.
  • 21
    Cervantes A, Rosello S, Roda D, Rodriguez-Braun E. The treatment of advanced gastric cancer: current strategies and future perspectives. Ann Oncol 2008; 19(Suppl 5): v1037.
  • 22
    Hsu PI, Hsieh HL, Lee J et al. Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer. Ann Surg Oncol 2009; 16: 168694.
  • 23
    Matsuoka J, Yashiro M, Sakurai K et al. Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res 2012; 174: 1305.
  • 24
    Warneke VS, Behrens HM, Hartmann JT et al. Cohort study based on the seventh edition of the TNM classification for gastric cancer: proposal of a new staging system. J Clin Oncol 2011; 29: 236471.
  • 25
    Kominea A, Konstantinopoulos PA, Kapranos N et al. Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer. J Cancer Res Clin Oncol 2004; 130: 2538.
  • 26
    Freedman ND, Ahn J, Hou L et al. Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer. Carcinogenesis 2009; 30: 717.
  • 27
    Zhang Y, Wang R, Song H et al. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer. Cancer Lett 2011; 303: 218.
  • 28
    Raleigh DR, Marchiando AM, Zhang Y et al. Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions. Mol Biol Cell 2010; 21: 120013.
  • 29
    Mariano C, Sasaki H, Brites D, Brito MA. A look at tricellulin and its role in tight junction formation and maintenance. Eur J Cell Biol 2011; 90: 78796.
  • 30
    Kojima T, Takasawa A, Kyuno D et al. Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial-mesenchymal transition in human pancreatic cancer cells. Exp Cell Res 2011; 317: 228898.